Moderna Helps This ETF, but It’s not the Only Catalyst

Moderna (MRNA) is one of the biggest stories in the biotechnology space this year because the company is one of the leading contenders to bring a coronavirus vaccine to market. To that point, Moderna stock soared Monday on news that its Covid-19 vaccine is making progress faster than many expected....
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.